TY  - JOUR

T1  - A phase 2, open‐label study of single‐dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy

JO  - Journal of the European Academy of Dermatology and Venereology

UR  - https://eprints.whiterose.ac.uk/177102/

PY  - 2021/02/01

AU  - Paller AS

AU  - Siegfried EC

AU  - Simpson EL

AU  - Cork MJ

AU  - Lockshin B

AU  - Kosloski MP

AU  - Kamal MA

AU  - Davis JD

AU  - Sun X

AU  - Pirozzi G

AU  - Graham NMH et al

ED  - 

DO  - DOI: 10.1111/jdv.16928

PB  - Wiley

VL  - 35

IS  - 2

SP  - 464

EP  - 475

Y2  - 2024/12/22

ER  -